在患有全身性硬化症的绝经前妇女中,卵巢储备的改变
A C Pecher1, J C Henes2,3, A Demin4
1Centre for Interdisciplinary Clinical Immunology, Rheumatology and Autoinflammatory Diseases, University Hospital Tübingen, Otfried-Mueller-Strasse 10, 72076, Tübingen, Germany.
Rheumatology international
|September 25, 2024
概括
与健康个体相比,患有全身性硬化症的妇女的抗穆勒激素 (AMH) 水平,这是卵巢储备的标志物,显着较低. 这一发现表明系统性硬化症患者的生育能力可能受到影响,需要定期监测AMH.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 自免疫性疾病 自免疫性疾病
- 临床免疫学临床免疫学
背景情况:
- 抗穆勒激素 (AMH) 是卵巢储备的一个关键指标.
- 卵巢储备减少是各种自身免疫性疾病中已知的并发症.
- 系统性硬化症 (SSc) 是一种自身免疫性疾病,可能会影响女性生育能力.
研究的目的:
- 为了将患有全身性硬化症的绝经前妇女的血清AMH水平与年龄相匹配的健康对照进行比较.
- 评估AMH作为在全身性硬化症中卵巢储备的替代标记物.
- 评估系统性硬化症妇女的潜在生育影响.
主要方法:
- 单中心研究涉及30名患有全身性硬化症的绝经前妇女和30名健康对照 (年龄18-40岁).
- 排除接受环胺治疗的患者.
- 使用电化学发光免疫试验测量血清AMH度.
主要成果:
- 与健康对照组相比,全身性硬化症患者的AMH水平 (955 ng/l) 显著降低 (1,940 ng/l;p < 0.01).
- 不同于对照组,系统性硬化症患者中没有观察到年龄和AMH水平之间的显著相关性.
- 在全身性硬化症患者中,AMH水平显著降低.
结论:
- 在患有全身性硬化症的绝经前妇女中,血清AMH水平显著降低,这表明卵巢储备减少.
- 建议对全身性硬化症患者,特别是年轻人进行定期的AMH监测.
- 这种监测可以帮助咨询关于最佳怀孕时间,生育能力的保护和治疗选择.
更多相关视频
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.0K
12:36Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
Published on: September 3, 2021
4.6K
相关概念视频
02:07Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
01:28Menopause
145
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
145